Incidence and risk factors of retreatment after three-monthly aflibercept therapy for exudative age-related macular degeneration

Though anti-vascular endothelial growth factor therapy has become the standard treatment for exudative age-related macular degeneration (AMD), retreatment after the initial loading injection is inevitable in most eyes with residual or recurrent exudative changes. In the present study, we studied 140...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikushima, Wataru, Sakurada, Yoichi, Yoneyama, Seigo, Sugiyama, Atsushi, Tanabe, Naohiko, Kume, Atsuki, Mabuchi, Fumihiko, Iijima, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339812/
https://www.ncbi.nlm.nih.gov/pubmed/28266609
http://dx.doi.org/10.1038/srep44020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339812/
https://www.ncbi.nlm.nih.gov/pubmed/28266609
http://dx.doi.org/10.1038/srep44020

Ejemplares similares